Staccato Loxapine in Migraine (Out Patient)

NCT00825500 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

366

Enrollment

UNKNOWN

Sponsor class

Conditions

Migraine Headache

Interventions

DRUG: Inhaled Placebo
DRUG: Inhaled Loxapine 1.25 mg
DRUG: Inhaled Loxapine 2.5 mg

Sponsor

Alexza Pharmaceuticals, Inc.